RÉSUMÉ
Understanding the interplay between kinetics and thermodynamics of polymer-mediated liquid-liquid phase separation is crucial for designing and implementing an amorphous solid dispersion formulation strategy for poorly water-soluble drugs. This work investigates the phase behaviors of a poorly water-soluble model drug, celecoxib (CXB), in a supersaturated aqueous solution with and without polymeric additives (PVP, PVPVA, HPMCAS, and HPMCP). Drug-polymer-water ternary phase diagrams were also constructed to estimate the thermodynamic behaviors of the mixtures at room temperature. The liquid-liquid phase separation onset point for CXB was detected using an inline UV/vis spectrometer equipped with a fiber optic probe. Varying CXB concentrations were achieved using an accurate syringe pump throughout this study. The appearance of the transient nanodroplets was verified by cryo-EM and total internal reflection fluoresence microscopic techniques. The impacts of various factors, such as polymer composition, drug stock solution pumping rates, and the types of drug-polymer interactions, are tested against the onset points of the CXB liquid-liquid phase separation (LLPS). It was found that the types of drug-polymer interactions, i.e., hydrogen bonding and hydrophobic interactions, are vital to the position and shapes of LLPS in the supersaturation drug solution. A relation between the behaviors of LLPS and its location in the CXB-polymer-water ternary phase diagram was drawn from the findings.
Sujet(s)
Célécoxib , Polymères , Solubilité , Thermodynamique , Eau , Polymères/composition chimique , Eau/composition chimique , Célécoxib/composition chimique , Cinétique , Chimie pharmaceutique/méthodes , Transition de phase ,RÉSUMÉ
It is very important to develop ideal electrocatalysts to accelerate the sulfur redox kinetics in both the discharging and charging processes for high-performance lithium-sulfur batteries. Herein, defect-rich cation-doped V2O5 yolk-shell microspheres are reported as a catalytic host of sulfur. The doping of W or Mo cations induces no impurities, broadens the lattice spacing of V2O5, and enriches the oxygen vacancy defects. Thus, the doped V2O5 host affords sufficient active sites for chemically anchoring polysulfides and promising catalytic effect on the mutual conversion between different sulfur intermediates. As a result, the S/W-V2O5 cathode delivers a discharging capacity of 1143.3 mA g-1 at an initial rate of 0.3 C and 681.8 mA g-1 at 5 C. Even under a sulfur loading of up to 5.5 mg cm-2 and a minimal electrolyte/sulfur ratio of 6 µL mg-1, the S/W-V2O5 cathode could still achieve good sulfur utilization and dependable cycle stability. Thus, this work offers an electrocatalytic host based on the cation doping strategy to greatly enhance the sulfur redox kinetics for high-performance Li-S batteries.
RÉSUMÉ
BACKGROUND: Despite advances in the treatment of ruptured Achilles tendon, imperfections of endogenous repair often leave patients symptomatic. Local administration of autologous conditioned serum (ACS) in patients with inflammatory, degenerative conditions has shown beneficial effects. PURPOSE: Because ACS also contains growth factors that should accelerate tendon healing, we studied the effect of ACS on the healing of transected rat Achilles tendon. STUDY DESIGN: Controlled laboratory study. METHODS: In preliminary in vitro experiments, rat tendons were incubated with ACS and the effect on the expression of Col1A1 and Col3A1 was assessed by real-time quantitative polymerase chain reaction. To test its effect in vivo, the Achilles tendons of 80 Sprague Dawley rats were transected and sutured back together. Ten rats from each group (ACS group, n = 40; control group, n = 40) were euthanized at 1, 2, 4, and 8 weeks postoperatively for biomechanical (n = 7) and histologic (n = 3) testing. Lysyl oxidase activity was assayed by a flurometric assay. The organization of repair tissue was assessed histologically with hematoxylin and eosin- and with Sirius red-stained sections, and with immunohistochemistry. RESULTS: Tendons exposed to ACS in vitro showed a greatly enhanced expression of the Col1A1 gene. The ACS-treated tendons were thicker, had more type I collagen, and an accelerated recovery of tendon stiffness and histologic maturity of the repair tissue. However, there were no differences in the maximum load to failure between groups up to week 8, perhaps because lysyl oxidase activities were unchanged. CONCLUSION AND CLINICAL RELEVANCE: Overall, our study demonstrates that treatment with ACS has the potential to improve Achilles tendon healing and should be considered as a treatment modality in man. However, as strength was not shown to be increased within the parameters of this study, the clinical importance of the observed changes in humans still needs to be defined.